Webinar: Vector vaccines adding new dimensions in protecting poultry health

Learn about the reduced risk of reversion to virulence, which could cause disease in the flock.

Jan 23rd, 2024
View Webinar

Ag Webseries Banner 250pxHVT vector vaccines have revolutionized poultry health management. These vaccines, unaffected by maternal antibodies, offer rapid protection against major diseases such as infectious bursal disease (IBD), Newcastle disease (ND), infectious laryngotracheitis (ILT), and more recently Avian influenza (AI). The advantages of hatchery vaccination include enhanced control over biosecurity, improved vaccine administration quality, and the potential for increased Bi Sponsored Logo 200pxautomation. Featured speakers include Dr. Michel Bublot, DVM, poultry vaccine consultant, and Dr. Stéphane Lemière, Head of Global Technical Services Poultry at Boehringer Ingelheim.

This webinar will broadcast at 7:00 AM CST (Chicago) / 1:00 PM GMT (London) / 9:00 PM CST (Beijing).

WHAT YOU’LL LEARN:

  1. Reduced Risk of Reversion to Virulence, which could cause disease in the flock.
  2. Potential for Broad-Spectrum Protection can be designed to protect against multiple strains of a pathogen or even different pathogens, which is beneficial in areas with diverse disease pressures.
  3. Ability to Differentiate Infected from Vaccinated Animal (DIVA) since Vector vaccines often allow for the differentiation between vaccinated animals and those that have been naturally infected, which is vital for disease surveillance and control programs.

This webinar is sponsored by Boehringer Ingelheim and presented by WATTPoultry.


Speaker Information:

Bublot Michel 90pxDr. Michel Bublot, DVM, poultry vaccine consultant

Michel Bublot is a veterinarian with a PhD in Virology from the University of Liège (Belgium). He has been working in R&D for Rhône-Mérieux, Merial, and Boehringer Ingelheim for 28 years. He has been heavily involved in the research and development of bivalent and trivalent HVT vector vaccines against IBD, ND, and ILT, as well as in a new genetically modified serotype 1 Marek’s disease vaccine. He is the author of numerous scientific publications and the inventor of several patents. He is currently pre-retired and has a consulting activity.


Bi Stephane 90pxDr. Stéphane Lemière, Head of Global Technical Services Poultry at Boehringer Ingelheim

Dr. Stéphane Lemière is a doctor in Veterinary Medicine recognized specialist in poultry pathology. A Member of the American Association of Avian Pathologists, the French Branch of the World Veterinary Poultry Association, the World Poultry Science Association Course Master Broiler Chicken Production WVEPAH. Dr. Lemiere is currently the Boehringer Ingelheim Global Head, Technical Services, in Lyon, France Leading the Global Poultry Veterinary Technical Services group.

View Webinar